Χώρα: Σιγκαπούρη
Γλώσσα: Αγγλικά
Πηγή: HSA (Health Sciences Authority)
POLYSACCHARIDES OF STREPTOCOCCUS PNEUMONIAE (PURIFIED)
SANOFI-AVENTIS SINGAPORE PTE. LTD.
J07AL01
25ug for each of the 23 serotypes
INJECTION
SUBCUTANEOUS, INTRAMUSCULAR
Prescription Only
SANOFI PASTEUR S.A.
1998-08-28
PNEUMO 23 POLYSACCHARIDE PNEUMOCOCCAL VACCINE 1. NAME OF THE MEDICINAL PRODUCT PNEUMO 23, SOLUTION FOR INJECTION IN PREFILLED SYRINGE POLYSACCHARIDE PNEUMOCOCCAL VACCINE 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Polysaccharides of _Streptococcus pneumoniae_ serotypes 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, 33F .................................................................................... 25 micrograms of each of the 23 serotypes, per 0.5 ml For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection in a prefilled syringe (0.5 ml). 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS This vaccine is indicated for the prevention of pneumococcal infections, in particular pneumonia, from the age of 2 years: • subjects older than 65 years of age, particularly elderly persons living in institutions, • frail subjects who are immunocompetent, subjects who are likely to be frequently hospitalized (diabetes, chronic bronchitis, respiratory insufficiency, heart failure, tobacco/alcohol dependency), • immunocompromised subjects (splenectomised subjects, subjects with sickle cell disease, nephrotic syndrome), and • subjects with a cerebrospinal fluid leak. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY _Adult Population _ _ _ Primary vaccination: injection of a dose of 0.5 ml. Revaccination: injection of a dose of 0.5 ml. 1 SGPneumo23xx14/171011 _Paediatric Population _ The posology used for the paediatric population is the same as that used for the adult population. REVACCINATION On the basis of current knowledge, the systematic revaccination of subjects who have received Διαβάστε το πλήρες έγγραφο